J Cyst Fibros. 2019 Jun 4. pii: S1569-1993(18)30844-0. doi: 10.1016/j.jcf.2019.05.007
van der Haak N1, King SJ2, Crowder T3, Kench A4, Painter C5, Saxby N6; Nutrition Guidelines for Cystic Fibrosis in Australia and New Zealand Authorship Group and Interdisciplinary Steering Committee.
- Cystic Fibrosis probably treated by Vitamin D (if use enough of the right type ) – Oct 2019
- Cystic Fibrosis and Vitamin D review with 2012 Guidelines - Nov 2019
- Vitamin D has been recommended for Cystic Fibrosis – a small dose helps a little – Aug 2018
- If vitamin D levels are less than 40 ng some children get cystic fibrosis – March 2018
- Powder-based Vitamin D may be gut-friendly (Cystic Fibrosis) – RCT Aug 2017
- Lungs with cystic fibrosis fail to activate vitamin D (poor CYP27B) – Feb 2016
- Cystic fibrosis problems cut in half by Omega-3 – RCT June 2015
- Cystic Fibrosis exacerbation reduced by Vitamin D (250,000 IU) – RCT May 2017
- Review of Cystic Fibrosis and Vitamin D PDF file, not web page: has the following
- Cystic Fibrosis category listing has
41 items along with related searches
"Average annual cost of CF $16,000" - it will be a while until the doctors are willing to switch to $4/year for Vitamin D
Optimal nutrition care is important in the management of cystic fibrosis (CF). This paper summarises the '2017 Nutrition Guidelines for Cystic Fibrosis in Australia and New Zealand (NZ)'. CF dietitians formulated 68 practice questions which were used to guide a systematic literature search and review of the evidence for nutrition in CF. Identified papers underwent quality and evidence assessment using the American Dietetic Association quality criteria checklist and the National Health and Medical Research Council of Australia (NHMRC) rankings. Evidence statements, graded recommendations and practice points were developed covering core nutrition topics (assessment and nutrition interventions including oral, enteral and micronutrient supplementation); nutrition-related co-morbidities (including pancreatic insufficiency, CF-related diabetes, bone health and distal intestinal obstruction syndrome); and key new topic areas (genetic modulator therapies, overweight/obesity and complementary therapies).
This paper showcases highlights from the guidelines, focussing on new topic areas and geographic and climate considerations for vitamin D, salt and hydration.